Abstract:Reactive oxygen species (ROS) contribute to cellular redox environment and serve as signaling molecules. Excessive ROS can lead to oxidative stress that are involved in a broad spectrum of physiological and pathological conditions. Stem cells have unique ROS regulation while cancer cells frequently show a constitutive oxidative stress that is associated with the invasive phenotype. Antioxidants have been proposed to forestall tumor progression while targeted oxidants have been used to destroy tumor cells. However, the delicate beneficial range of ROS levels for stem cells and tumor cells under distinct contexts remains elusive. Here, we used Drosophila midgut intestinal stem cell (ISCs) as an in vivo model system to tackle this question. The ROS levels of ISCs remained low in comparison to that of differentiated cells and increased with ageing, which was accompanied by elevated proliferation of ISCs in aged Drosophila. Neither upregulation nor downregulation of ROS levels significantly affected ISCs, implicating an intrinsic homeostatic range of ROS in ISCs. Interestingly, we observed similar moderately elevated ROS levels in both tumor-like ISCs induced by Notch (N) depletion and extracellular matrix (ECM)-deprived ISCs induced by β-integrin (mys) depletion. Elevated ROS levels further promoted the proliferation of tumor-like ISCs while reduced ROS levels suppressed the hyperproliferation phenotype; on the other hand, further increased ROS facilitated the survival of ECM-deprived ISCs while reduced ROS exacerbated the loss of ECM-deprived ISCs. However, N- and mys-depleted ISCs, which resembled metastatic tumor cells, harbored even higher ROS levels and were subjected to more severe cell loss, which could be partially prevented by ectopic supply of antioxidant enzymes, implicating a delicate pro-surviving and proliferating range of ROS levels for ISCs. Taken together, our results revealed stem cells can differentially respond to distinct ROS levels under various conditions and suggested that the antioxidant-based intervention of stem cells and tumors should be formulated with caution according to the specific situations.

Reactive Oxygen Species in Normal and Tumor Stem Cells

Regulation of reactive oxygen species in stem cells and cancer stem cells

Predominant factors influencing reactive oxygen species in cancer stem cells

Roles of Reactive Oxygen Species in the Fate of Stem Cells

Roles of Reactive Oxygen Species in Pluripotent Stem Cell Functions

Reactive Oxygen Species and Mitochondrial Homeostasis as Regulators of Stem Cell Fate and Function

Association of reactive oxygen species levels and radioresistance in cancer stem cells

Context-dependent responses of Drosophila intestinal stem cells to intracellular reactive oxygen species

Targeted Therapy of Tumors and Cancer Stem Cells based on Oxidant-Regulated Redox Pathway and its Mechanism

Reactive oxygen species and hematopoietic stem cell senescence

Redox homeostasis: the linchpin in stem cell self-renewal and differentiation

The role of ROS in tumour development and progression

Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?

Reactive oxygen species in embryonic stem cells physiology

Ros Stress in Cancer Cells and Therapeutic Implications

Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development

Models of Reactive Oxygen Species in Cancer

Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment

Controlling Cancer Cells Using Reactive Oxygen Species

New Insights into Redox Regulation of Stem Cell Self-Renewal and Differentiation

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy